Relapsed and/or Refractory Non-Hodgkin T-cell Lymphoma
1 clinical trials · Condition
◉ Watch Relapsed and/or Refractory Non-Hodgkin T-cell Lymphoma
| Record | Firm | Date |
|---|---|---|
| Phase II of Lenalidomide After Salvage Therapy in R/R Non-Hodgkin T-cell Lymphoma (NCT03730740) | Samsung Medical Center | 2018-11-16 |
Track Relapsed and/or Refractory Non-Hodgkin T-cell Lymphoma automatically
Every clearance here is in the API, with alerts when new ones post.